Adipocyte fatty acid binding protein: A novel adipokine involved in the pathogenesis of metabolic and vascular disease?

Diabetologia

Volumn 56, Issue 1, 2013, Pages 10-21

  Kralisch, S ^a,b   Fasshauer, M ^a,b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Adipose tissue; AFABP; Cardiovascular disease; Insulin resistance; Metabolic syndrome; Obesity; Review

Indexed keywords

ATORVASTATIN; FATTY ACID BINDING PROTEIN 4; TRIACYLGLYCEROL;

AFABP GENE; ATHEROSCLEROSIS; BODY WEIGHT; CELL FUNCTION; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DRUG TARGETING; DYSLIPIDEMIA; GENE FUNCTION; GENE IDENTIFICATION; GLUCOSE METABOLISM; HETEROZYGOSITY; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC DISORDER; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; VASCULAR DISEASE;

ADIPOCYTES; ADIPOKINES; ANIMALS; ATHEROSCLEROSIS; FATTY ACID-BINDING PROTEINS; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; METABOLIC SYNDROME X; VASCULAR DISEASES;

EID: 84871608927     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2737-4     Document Type: Review

References (91)

1. Ahima RS, Flier JS (2000) Leptin. Annu Rev Physiol 62:413-437 (Pubitemid 30618269)
2. Fruebis J, Tsao TS, Javorschi S et al. (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 98:2005-2010 (Pubitemid 32165613)
3. Baxa CA, Sha RS, Buelt MK et al. (1989) Human adipocyte lipid-binding protein - purification of the protein and cloning of its complementary-DNA. Biochemistry 28:8683-8690 (Pubitemid 19278525)
4. Fu YC, Luo NL, Lopes-Virella MF, Garvey WT (2002) The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages. Atherosclerosis 165:259-269 (Pubitemid 35333352)
5. Elmasri H, Karaaslan C, Teper Y et al. (2009) Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J 23:3865-3873
6. Bernlohr DA, Angus CW, Lane MD, Bolanowski MA, Kelly TJ (1984) Expression of specific mRNAs during adipose differentiation: identification of an mRNA encoding a homologue of myelin P2 protein. Proc Natl Acad Sci USA 81:5468-5472 (Pubitemid 14000508)
7. Bernlohr DA, Bolanowski MA, Kelly TJ, Lane MD (1985) Evidence for an increase in transcription of specific mRNAs during differentiation of 3t3-l1 preadipocytes. J Biol Chem 260:5563-5567 (Pubitemid 15008113)
8. Bernlohr DA, Doering TL, Kelly TJ, Lane MD (1985) Tissue specific expression of p422 protein, a putative lipid carrier, in mouse adipocytes. Biochem Biophys Res Commun 132:850-855 (Pubitemid 16198701)
9. Smith PJ, Wise LS, Berkowitz R, Wan C, Rubin CS (1988) Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem 263:9402-9408
10. Yang VW, Christy RJ, Cook JS, Kelly TJ, Lane MD (1989) Mechanism of regulation of the 422(Ap2) gene by CAMP during preadipocyte differentiation. Proc Natl Acad Sci USA 86:3629-3633
11. Christy RJ, Yang VW, Ntambi JM et al. (1989) Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. Genes Dev 3:1323-1335
12. Cabré A, Lázaro I, Girona J et al. (2007) Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. Atherosclerosis 195:e150-e158 (Pubitemid 47569987)
13. Kletzien RF, Foellmi LA, Harris PKW, Wyse BM, Clarke SD (1992) Adipocyte fatty acid-binding protein: regulation of gene expression in vivo and in vitro by an insulin-sensitizing agent. Mol Pharmacol 42:558-562 (Pubitemid 23027615)
14. Fisher RM, Eriksson P, Hoffstedt J et al. (2001) Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals. Diabetologia 44:1268-1273 (Pubitemid 33010503)
15. Coe NR, Bernlohr DA (1998) Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim Biophys Acta 1391:287-306 (Pubitemid 28202126)
16. Lalonde JM, Bernlohr DA, Banaszak LJ (1994) X-ray crystallographic structures of adipocyte lipid-binding protein complexed with palmitate and hexadecanesulfonic acid - properties of cavity binding-sites. Biochemistry 33:4885-4895 (Pubitemid 24158438)
17. Xu ZH, Bernlohr DA, Banaszak LJ (1993) The adipocyte lipid-binding protein at 1.6-a resolution - crystal-structures of the apoprotein and with bound saturated and unsaturated fatty-acids. J Biol Chem 268:7874-7884 (Pubitemid 23120364)
18. Liou HL, Storch J (2001) Role of surface lysine residues of adipocyte fatty acid-binding protein in fatty acid transfer to phospholipid vesicles. Biochemistry 40:6475-6485 (Pubitemid 32472738)
19. Shen WJ, Liang Y, Hong R et al. (2001) Characterization of the functional interaction of adipocyte lipid-binding protein with hormone-sensitive lipase. J Biol Chem 276:49443-49448
20. Smith AJ, Thompson BR, Sanders MA, Bernlohr DA (2007) Interaction of the adipocyte fatty acid-binding protein with the hormone-sensitive lipase - regulation by fatty acids and phosphorylation. J Biol Chem 282:32424-32432 (Pubitemid 350106440)
21. Hertzel AV, Hellberg K, Reynolds JM et al. (2009) Identification and characterization of a small molecule inhibitor of fatty acid binding proteins. J Med Chem 52:6024-6031
22. Smith AJ, Sanders MA, Juhlmann BE, Hertzel AV, Bernlohr DA (2008) Mapping of the hormone-sensitive lipase binding site on the adipocyte fatty acid-binding protein (AFABP) identification of the charge quartet on the AFABP/aP2 helix-turn-helix domain. J Biol Chem 283:33536-33543
23. Adida A, Spener F (2006) Adipocyte-type fatty acid-binding protein as inter-compartmental shuttle for peroxisome proliferator activated receptor γ agonists in cultured cell. Biochim Biophys Acta 1761:172-181
24. Gillilan RE, Ayers SD, Noy N (2007) Structural basis for activation of fatty acid-binding protein 4. J Mol Biol 372:1246-1260 (Pubitemid 47374720)
25. Ayers SD, Nedrow KL, Gillilan RE, Noy N (2007) Continuous nucleocytoplasmic shuttling underlies transcriptional activation of PPAR gamma by FABP4. Biochemistry 46:6744-6752 (Pubitemid 46906405)
26. Tan N-S, Shaw NS, Vinckenbosch N, Liu P, Yasmin R et al. (2002) Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol 22:5114-5127 (Pubitemid 34700702)
27. Hotamisligil GS, Johnson RS, Distel RJ et al. (1996) Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274:1377-1379 (Pubitemid 26391462)
28. Coe NR, Simpson MA, Bernlohr DA (1999) Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J Lipid Res 40:967-972 (Pubitemid 29220539)
29. -/-)) mice after short-term high-fat feeding - functional compensation by the keritinocyte fatty acid binding protein. Diabetes 49:904-911 (Pubitemid 30349411)
30. Maeda K, Cao H, Kono K, Gorgun CZ, Furuhashi M et al. (2005) Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab 1:107-119 (Pubitemid 43960591)
31. Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS (2000) Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141:3388-3396 (Pubitemid 32269028)
32. -/-) mice. Am J Physiol Endocrinol Metab 288:E187-E193 (Pubitemid 40023806)
33. Cao H, Maeda K, Gorgun CZ et al. (2006) Regulation of metabolic responses by adipocyte/macrophage fatty acid-binding proteins in leptin-deficient mice. Diabetes 55:1915-1922 (Pubitemid 44509962)
34. -/- mice. Diabetes 48:1987-1994 (Pubitemid 29458361)
35. Furuhashi M, Tuncman G, Gorgun CZ et al. (2007) Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 447:959-965 (Pubitemid 46975747)
36. Lan H, Cheng CC, Kowalski TJ et al. (2011) Small-molecule inhibitors of FABP4/5 ameliorate dyslipidaemia but not insulin resistance in mice with diet-induced obesity. J Lipid Res 52:646-656
37. Yang R, Castriota G, Chen Y et al. (2011) RNAi-mediated germline knockdown of FABP4 increases body weight but does not improve the deranged nutrient metabolism of diet-induced obese mice. Int J Obes (Lond) 35:217-225
38. Makowski L, Boord JB, Maeda K et al. (2001) Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 7:699-705 (Pubitemid 32588026)
39. Boord JB, Maeda K, Makowski L et al. (2002) Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Arterioscler Thromb Vasc Biol 22:1686-1691
40. Boord JB, Maeda K, Makowski L et al. (2004) Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. Circulation 110:1492-1498 (Pubitemid 39238029)
41. Lee MYK, Li HY, Xiao Y et al. (2011) Chronic administration of BMS309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells. Br J Pharmacol 162:1564-1576
42. Tuncman G, Erbay E, Hom X et al. (2006) A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc Natl Acad Sci USA 103:6970-6975
43. Chan KHK, Song YQ, Hsu YH et al. (2010) Common genetic variants in fatty acid-binding protein-4 (FABP4) and clinical diabetes risk in the Women's Health Initiative observational study. Obesity 18:1812-1820
44. Makowski L, Brittingham KC, Reynolds JM, Suttles J, Hotamisligil GS (2005) The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. J Biol Chem 280:12888-12895
45. Shum BO, Mackay CR, Gorgun CZ et al. (2006) The adipocyte fatty acid-binding protein aP2 is required in allergic airway inflammation. J Clin Invest 116:2183-2192 (Pubitemid 44162327)
46. Reynolds JM, Liu Q, Brittingham KC et al. (2007) Deficiency of fatty acid-binding proteins in mice confers protection from development of experimental autoimmune encephalomyelitis. J Immunol 179:313-321 (Pubitemid 46986547)
47. Kazemi MR, McDonald CM, Shigenaga JK, Grunfeld C, Feingold KR (2005) Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists. Arterioscler Thromb Vasc Biol 25:1220-1224 (Pubitemid 40776612)
48. Shi H, Kokoeva MV, Inouye K et al. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015-3025 (Pubitemid 44684486)
49. Hui X, Li H, Zhou Z et al. (2010) Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1. J Biol Chem 285:10273-10280
50. Erbay E, Babaev VR, Mayers JR et al. (2009) Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis. Nat Med 15:1383-1391
51. Fu YC, Luo LH, Luo NL, Garvey WT (2006) Lipid metabolism mediated by adipocyte lipid binding protein (ALBP/aP2) gene expression in human THP-1 macrophages. Atherosclerosis 188:102-111 (Pubitemid 44142544)
52. Wang XQ, Yang K, He YS, Lu L, Shen WF (2011) Receptor mediated elevation in FABP4 levels by advanced glycation end products induces cholesterol and triacylglycerol accumulation in THP-1 Macrophages. Lipids 46:479-486
53. Saksi J, Nuotio K, Sonninen R et al. (2011) Gene expression differences between stroke-associated and asymptomatic carotid plaques. J Mol Med 89:1015-1026
54. Holm S, Ueland T, Dahl TB et al. (2011) Fatty acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke. PLoS One 6:e28785
55. Agardh HE, Folkersen L, Ekstrand J et al. (2011) Expression of fatty acid-binding protein 4/aP2 is correlated with plaque instability in carotid atherosclerosis. J Int Med 269:200-210
56. Peeters W, de Kleijn DPV, Vink A et al. (2011) Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events. Eur Heart J 32:1758-1768
57. Llaverias G, Noé V, Peñuelas S et al. (2004) Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages. Biochem Biophys Res Commun 318:265-274 (Pubitemid 38526275)
58. Elmasri H, Ghelfi E, Yu C et al. (2012) Endothelial cell-fatty acid binding protein 4 promotes angiogenesis: role of stem cell factor/c-kit pathway. Angiogenesis 15:457-468
59. Xu A, Wang Y, Xu JY et al. (2006) Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 52:405-413
60. Veerkamp JH, Maatman RG (1995) Cytoplasmic fatty acid-binding proteins: their structure and genes. Prog Lipid Res 34:17-52
61. Reese-Wagoner A, Thompson J, Banaszak L (1999) Structural properties of the adipocyte lipid binding protein. Biochim Biophys Acta 1441:106-116 (Pubitemid 29537731)
62. Radisky DC, Stallings-Mann M, Hirai Y, Bissell MJ (2009) Single proteins might have dual but related functions in intracellular and extracellular microenvironments. Nat Rev Mol Cell Biol 10:228-234
63. Mohan SK, Rani SG, Yu C (2010) The heterohexameric complex structure, a component in the non-classical pathway for fibroblast growth factor 1 (FGF1) secretion. J Biol Chem 285:15464-15475
64. Aoki N, Jin-no S, Nakagawa Y et al. (2007) Identification and characterization of microvesicles secreted by 3T3-L1 adipocytes: redox- and hormone-dependent induction of milk fat globule-epidermal growth factor 8-associated microvesicles. Endocrinology 148:3850-3862 (Pubitemid 47105834)
65. Lamounier-Zepter V, Look C, Alvarez J et al. (2009) Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res 105:326-334
66. Stejskal D, Karpisek M (2006) Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome? Eur J Clin Invest 36:621-625 (Pubitemid 44213828)
67. Coll B, Cabre A, Alonso-Villaverde C et al. (2008) The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected patients. Atherosclerosis 199:147-153 (Pubitemid 351842692)
68. Cabre A, Lazaro I, Cofan M et al. (2010) FABP4 plasma levels are increased in familial combined hyperlipidemia. J Lipid Res 51:1173-1178
69. Milner KL, van der Poorten D, Xu A et al. (2009) Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease. Hepatology 49:1926-1934
70. Yun KE, Kim SM, Choi KM, Park HS (2009) Association between adipocyte fatty acid-binding protein levels and childhood obesity in Korean children. Metabolism 58:798-802
71. Tonjes A, Kralisch S, Lossner U et al. (2012) Metabolic and genetic predictors of circulating adipocyte fatty acid-binding protein. Int J Obes 36:766-773
72. Cabre A, Lazaro I, Girona J et al. (2008) Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes. J Lipid Res 49:1746-1751
73. Hsu BG, Chen YC, Lee RP et al. (2010) Fasting serum level of fatty-acid-binding protein 4 positively correlates with metabolic syndrome in patients with coronary artery disease. Circ J 74:327-331
74. Yeung DC, Xu A, Cheung CW et al. (2007) Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler Thromb Vasc Biol 27:1796-1802 (Pubitemid 47207176)
75. Rhee EJ, Lee WY, Park CY et al. (2009) The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults. Eur J Endocrinol 160:165-172
76. Doi M, Miyoshi T, Hirohata S et al. (2011) Association of increased plasma adipocyte fatty acid-binding protein with coronary artery disease in non-elderly men. Cardiovasc Diabetol 10:44
77. Miyoshi T, Onoue G, Hirohata A et al. (2010) Serum adipocyte fatty acid-binding protein is independently associated with coronary atherosclerotic burden measured by intravascular ultrasound. Atherosclerosis 211:164-169
78. Bao YQ, Lu ZG, Zhou M et al. (2011) Serum levels of adipocyte fatty acid-binding protein are associated with the severity of coronary artery disease in chinese women. PLoS One 6:e19115
79. Pala L, Monami M, Ciani S et al. (2012) Adipokines as possible new predictors of cardiovascular diseases: a case control study. J Nutr Metab 2012:1-5
80. Yoo HJ, Kim S, Park MS et al. (2011) Serum adipocyte fatty acid-binding protein is associated independently with vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography. J Clin Endocrinol Metab 96:E488-E492
81. Choi KM, Kim TN, Yoo HJ et al. (2009) Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women. Clin Endocrinol 70:569-574
82. Simon I, Escote X, Vilarrasa N et al. (2009) Adipocyte fatty acid-binding protein as a determinant of insulin sensitivity in morbid-obese women. Obesity 17:1124-1128
83. Corripio R, Gonzalez-Clemente JM, Perez-Sanchez J et al. (2010) Weight loss in prepubertal obese children is associated with a decrease in adipocyte fatty-acid-binding protein without changes in lipocalin-2: a 2-year longitudinal study. Eur J Endocrinol 163:887-893
84. Stejskal D, Karpisek M, Bronsky J (2008) Serum adipocyte-fatty acid binding protein discriminates patients with permanent and temporary body weight loss. J Clin Lab Ana 22:380-382
85. Wu Y-W, Kao H-L, Huang C-L et al. (2012) The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers. Eur J Nucl Med Mol Imaging 39:399-407
86. Xu A, Tso AW, Cheung BM et al. (2007) Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation 115:1537-1543 (Pubitemid 46648638)
87. Choi KM, Yannakoulia M, Park MS et al. (2011) Serum adipocyte fatty acid-binding protein, retinol-binding protein 4, and adiponectin concentrations in relation to the development of the metabolic syndrome in Korean boys: a 3-y prospective cohort study. Am J Clin Nutr 93:19-26
88. Tso AW, Xu A, Sham PC et al. (2007) Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care 30:2667-2672 (Pubitemid 47547818)
89. Furuhashi M, Ishimura S, Ota H et al. (2011) Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease. PLoS One 6:e27356
90. Tso AWK, Lam TKY, Xu A et al. (2011) Serum adipocyte fatty acid-binding protein associated with ischemic stroke and early death. Neurology 76:1968-1975
91. von Eynatten M, Breitling LP, Roos M et al. (2012) Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 32:2327-2335